pharma

Emerging API and Intermediates Maker Focuses on Scale Post-Listing

● Feb 19, 2026

Anlon Healthcare Ltd (NSE: AHCL), a relatively recent entrant to the public markets following its 2025 IPO, reported its Q3...

Indoco Remedies Q3 Revenue Slips as Losses Widen Despite Operating Recovery

● Feb 3, 2026

Indoco Remedies Limited (NSE:INDOCO) closed at ₹235.00 on February 3, 2026, up 10.88% from the previous close of ₹211.94, surging...

Indegene posts 31% revenue jump in Q3, crosses $100 million quarterly milestone

● Jan 30, 2026

Indegene Ltd (NSE:INDGN), a life sciences services firm reported more than 30% year-on-year revenue growth for the December quarter, crossing...

Piramal Pharma Ltd Q3 FY 2026 Financial Results: Navigating Cyclical Headwinds with Strategic Adjustments

● Jan 29, 2026

Piramal Pharma Ltd (NSE: PPLPHARMA), a leading global pharmaceutical and life sciences company headquartered in Mumbai, reported its financial results...

Aurobindo Pharma Ltd Q2FY25; 9% rise in Profits

● Dec 2, 2024

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003...

Laurus Labs Ltd Q4 FY24 Earnings Conference Call Insights

● Apr 26, 2024

Key highlights from Laurus Labs Ltd (LAURUSLABS) Q4 FY24 Earnings Concall R&D Progress Advanced several pipeline projects across offerings and...

Gland Pharma Ltd Q3FY24; 17% fall in Profits

● Mar 21, 2024

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume...

EPL Ltd Q3FY24; 38% rise in Profits

● Mar 18, 2024

EPL Limited (formerly known as Essel Propack Limited),is the largest specialty packaging global company, manufacturing laminated plastic tubes catering to...

Balaji Amines Ltd Q3FY24; 33% fall in Profits

● Feb 14, 2024

Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main...

Ajanta Pharma Ltd Q3FY24; 56% rise in Profits

● Feb 14, 2024

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report...